PREPARE’s ALIC4E clinical trial is the only study that is currently randomising patients to receive antiviral treatment or not. This study will answer the question about whether Ostletamivir is clinically and/ or cost effective or not when treating primary care patents with influenza-like illness. A press release with more information about this exciting and innovative trial has been released through the University of Oxford.